In our next On Target podcast, Dr Akila Viswanathan talks with Dr Jean Wright from Sibley Memorial Hospital about treating breast cancer. In this preview, Dr Wright explains the different types of breast cancer and their frequency of diagnosis. To listen to the full podcast, click here: http://bit.ly/2HmvCfP
Breast Cancer
DELFI Blood Test: A Brand New Way of Detecting Multiple Cancers
Posted by | Prevention/ScreeningA new cancer test developed by Johns Hopkins Kimmel Cancer Center scientists screens for seven types of cancer in a completely unique way. DELFI is a new and different kind of cancer screening test. Rather than finding cancer gene mutations or chemical alterations to the DNA, known as epigenetic changes, it detects unique patterns in(...)
Cancer Matters with Dr. Bill Nelson – Breast Cancer Survivorship
Posted by | podcastIn the next podcast from Johns Hopkins Kimmel Cancer Director Dr Bill Nelson, he speaks with Dr Antonio Wolff about treating breast cancer with a focus on survivorship. In this preview, Dr Wolff says each patient is given an individualized care plan that targets the type of breast cancer they have. To listen to the(...)
Cancer Matters with Dr. Bill Nelson – Breast Cancer Prevention
Posted by | podcastIn our next podcast, Dr Bill Nelson speaks with Dr John Fetting and breast cancer survivor Leslie Ries from the Fetting Fund about the current state of breast cancer prevention. In this preview, Leslie explains the importance of prioritizing prevention over waiting until a diagnosis . To listen to the full podcast, click here: http://bit.ly/2IlaqIq
Cancer Matters with Dr. Bill Nelson – Breast Cancer in Young Women
Posted by | podcastIn this podcast, Dr Bill Nelson speaks with Dr Vered Stearns and Elissa Bantug, Research Program Manager at the Johns Hopkins Breast Center, about how breast cancer care in younger women is different from older women, the resources available to them at the Johns Hopkins Kimmel Cancer Center and a grant from the CDC that(...)
A New Issue of Breast Matters
Posted by | Patient Stories, precision medicine, Prevention/Screening, Research, Survivorship, treatmentThe latest issue of Breast Matters is now out on newsstands, and we have it here for you in our brand new digital design. The new issue includes news on our GAITWAY Tumor board, a group of more than a dozen experts who match treatments to the unique genetic characteristics of patients’ tumors. It also(...)
Epigenetic Drugs Reset Genes in Breast, Colon Cancers But Didn’t Shrink Tumors
Posted by | Research, treatment--Two clinical trials suggest promise for using these medications in combination with other cancer therapies Two clinical trials using combinations of drugs meant to change cancer epigentics —or the way tumors express genes — failed at shrinking colon and breast tumors. However, these trials open the door for others currently in the works to combine(...)
Natural Remedies Being Studied for Breast Cancer
Posted by | treatmentIn your Facebook feed, in conversations with friends, in a magazine article—the talk about natural remedies for preventing and treating breast cancer seems to pop up everywhere. But which natural products are actually being tested in the lab and in clinical trials, and what’s the evidence for their effectiveness? Saraswati Sukumar, Ph.D., Johns Hopkins oncology(...)
Can Magnolia Help Break the Link Between Obesity and Breast Cancer?
Posted by | Research--This post was written by freelance writer Becky Ham. A compound made from the tree’s bark shows promise against tumors spurred by the leptin hormone. Stand under the glossy green canopy of a southern magnolia in full bloom, and you’ll be dazzled by this queen tree’s show of hundreds of highly perfumed ivory blossoms, each(...)
Avon awards Kimmel Cancer Center more than $1 million for breast cancer research and support
Posted by | ResearchThis past weekend, the Avon Foundation held its 14th annual event in Washington, D.C. to raise funds for breast cancer research and education. More than 1,900 participants from 41 states and Washington, D.C. walked 39.3 miles in the AVON 39 The Walk to End Breast Cancer. Of the total $4.8 million raised during the weekend event,(...)